Related Experiment Videos
CGRP receptors: a headache to study, but will antagonists prove therapeutic in migraine?
Susan D Brain1, David R Poyner, Raymond G Hill
1Centre for Cardiovascular Biology & Medicine, New Hunt's House, King's College, Guy's Campus, SE1 1UL., London, UK. sue.brain@kcl.ac.uk
Trends in Pharmacological Sciences
|February 7, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Investigating hierarchical control among functional networks disrupted by opioid use disorder using effective connectivity.
Imaging neuroscience (Cambridge, Mass.)·2026
Phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) inhibitors reduce vascular inflammation in vitro and in vivo.
British journal of pharmacology·2025
TNIK: A redox sensor in endothelial cell permeability.
Science advances·2024
Bias from within: intracellular allosterism and the ICL2 hub.
Trends in pharmacological sciences·2026
Closing AI drug-regulatory gaps through harmonized oversight.
Trends in pharmacological sciences·2026
Midnolin-directed protein degradation beyond ubiquitin.
Trends in pharmacological sciences·2026
Deubiquitinases in mitophagy: therapeutic control of mitochondrial quality.
Trends in pharmacological sciences·2026
AI virtual cells for drug discovery and pharmacology.
Trends in pharmacological sciences·2026
Pyroptotic pores reopen the case for caspase inhibitors.
Trends in pharmacological sciences·2026
State-dependent inhibition of LRRC8 volume-regulated anion channels by DCPIB.
The Journal of general physiology·2026
Beyond Omalizumab: Emerging Biologic and Small Molecule Therapies in Chronic Spontaneous Urticaria.
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Madecassic acid attenuates sepsis-associated acute lung injury by regulating the PI3K/AKT/mTOR pathway to mediate anti-inflammatory, antioxidant and anti-apoptotic effects.
Pakistan journal of pharmaceutical sciences·2026
Primary Hyperaldosteronism as a Cause of Resistant Hypertension: A Case Report.
Clinical case reports·2026